VTR(SZ:300381) Zheng Quan Zhi Xing·2025-05-12 12:05Core Viewpoint - The legal opinion provided by Beijing Deheng (Shenzhen) Law Firm confirms that the 2024 annual general meeting of Guangdong Yidoli Biotechnology Co., Ltd. was convened and conducted in compliance with relevant laws and regulations, ensuring the legitimacy of the meeting and its resolutions [1][16]. Group 1: Meeting Procedures - The annual general meeting is scheduled for May 12, 2025, and the notice was published in accordance with legal requirements, with a 20-day notice period before the meeting [5]. - The meeting was held at the company's conference center in Zhuhai, and the actual time and location matched the notice provided [5][6]. - The network voting was conducted on the same day, with specific time slots for voting through different systems [6]. Group 2: Attendance and Qualifications - A total of 109 participants attended the meeting, representing 168,542,143 shares, which is 35.1002% of the total voting shares [7]. - Among the attendees, 4 participants were present at the physical meeting, representing 143,687,478 shares (29.9241%), while 105 participated via online voting, representing 24,854,665 shares (5.1762%) [7]. - The qualifications of the attendees and the convenor of the meeting were verified and deemed valid according to relevant laws and regulations [8]. Group 3: Voting Procedures and Results - The voting process included both on-site and online voting, with no modifications to the agenda items as listed in the notice [9]. - The voting was conducted in accordance with legal requirements, with representatives overseeing the counting of votes [9]. - The resolutions passed included the approval of the 2024 annual report, with 99.5046% of votes in favor, and other key reports also received similar overwhelming support [10][11][12][13][14][15][16].